XML 23 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Total United Natural Foods, Inc. Stockholders’ Equity
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Noncontrolling Interests
Beginning balance (in shares) at Jul. 31, 2021     57.0 0.6        
Beginning balance at Jul. 31, 2021 $ 1,514 $ 1,515 $ 1 $ (24) $ 599 $ (39) $ 978 $ (1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock vestings (in shares)     1.8          
Restricted stock vestings (35) (35)     (35)      
Share-based compensation 23 23     23      
Other comprehensive income (loss) 30 30       30    
Distributions to noncontrolling interests (3)             (3)
Proceeds from issuance of common stock, net 9 9     9      
Net income 145 142         142 3
Ending balance (in shares) at Jan. 29, 2022     58.8 0.6        
Ending balance at Jan. 29, 2022 1,683 1,684 $ 1 $ (24) 596 (9) 1,120 (1)
Beginning balance (in shares) at Oct. 30, 2021     58.7 0.6        
Beginning balance at Oct. 30, 2021 1,587 1,589 $ 1 $ (24) 582 (24) 1,054 (2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock vestings (in shares)     0.1          
Restricted stock vestings (2) (2)     (2)      
Share-based compensation 12 12     12      
Other comprehensive income (loss) 15 15       15    
Distributions to noncontrolling interests (1)             (1)
Proceeds from issuance of common stock, net 4 4     4      
Net income 68 66         66 2
Ending balance (in shares) at Jan. 29, 2022     58.8 0.6        
Ending balance at Jan. 29, 2022 $ 1,683 1,684 $ 1 $ (24) 596 (9) 1,120 (1)
Beginning balance (in shares) at Jul. 30, 2022 58.3   58.9 0.6        
Beginning balance at Jul. 30, 2022 $ 1,792 1,791 $ 1 $ (24) 608 (20) 1,226 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock vestings (in shares)     2.0          
Restricted stock vestings (39) (39)     (39)      
Share-based compensation 23 23     23      
Repurchases of common stock (in shares)       0.7        
Repurchases of common stock (29) (29)   $ (29)        
Other comprehensive income (loss) 11 11       11    
Distributions to noncontrolling interests (2)             (2)
Net income $ 89 85         85 4
Ending balance (in shares) at Jan. 28, 2023 59.6   60.9 1.3        
Ending balance at Jan. 28, 2023 $ 1,845 1,842 $ 1 $ (53) 592 (9) 1,311 3
Beginning balance (in shares) at Oct. 29, 2022     60.9 1.0        
Beginning balance at Oct. 29, 2022 1,835 1,835 $ 1 $ (36) 583 (5) 1,292 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock vestings (2) (2)     (2)      
Share-based compensation 11 11     11      
Repurchases of common stock (in shares)       0.3        
Repurchases of common stock (17) (17)   $ (17)        
Other comprehensive income (loss) (4) (4)       (4)    
Net income $ 22 19         19 3
Ending balance (in shares) at Jan. 28, 2023 59.6   60.9 1.3        
Ending balance at Jan. 28, 2023 $ 1,845 $ 1,842 $ 1 $ (53) $ 592 $ (9) $ 1,311 $ 3